Logo image of HCWC

HEALTHY CHOICE WELLNESS CORP (HCWC) Stock Fundamental Analysis

USA - NYSEARCA:HCWC - US42227T1051 - Common Stock

0.67 USD
+0.04 (+5.93%)
Last: 10/10/2025, 9:32:51 PM
0.677 USD
+0.01 (+1.04%)
After Hours: 10/10/2025, 9:32:51 PM
Fundamental Rating

3

Taking everything into account, HCWC scores 3 out of 10 in our fundamental rating. HCWC was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. HCWC has a bad profitability rating. Also its financial health evaluation is rather negative. HCWC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

HCWC had negative earnings in the past year.
In the past year HCWC had a positive cash flow from operations.
HCWC Yearly Net Income VS EBIT VS OCF VS FCFHCWC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of HCWC (-11.71%) is worse than 84.62% of its industry peers.
With a Return On Equity value of -73.95%, HCWC is not doing good in the industry: 87.18% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.71%
ROE -73.95%
ROIC N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWC Yearly ROA, ROE, ROICHCWC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

HCWC's Gross Margin of 39.65% is amongst the best of the industry. HCWC outperforms 87.18% of its industry peers.
In the last couple of years the Gross Margin of HCWC has grown nicely.
HCWC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
HCWC Yearly Profit, Operating, Gross MarginsHCWC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
HCWC has about the same amout of shares outstanding than it did 1 year ago.
HCWC has a worse debt/assets ratio than last year.
HCWC Yearly Shares OutstandingHCWC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
HCWC Yearly Total Debt VS Total AssetsHCWC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 2.18 indicates that HCWC is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.18, HCWC is doing worse than 71.79% of the companies in the same industry.
HCWC has a debt to FCF ratio of 5.54. This is a neutral value as HCWC would need 5.54 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.54, HCWC is in line with its industry, outperforming 56.41% of the companies in the same industry.
HCWC has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.51, HCWC is not doing good in the industry: 79.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 5.54
Altman-Z 2.18
ROIC/WACCN/A
WACC9.05%
HCWC Yearly LT Debt VS Equity VS FCFHCWC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

HCWC has a Current Ratio of 1.10. This is a normal value and indicates that HCWC is financially healthy and should not expect problems in meeting its short term obligations.
HCWC has a Current ratio (1.10) which is comparable to the rest of the industry.
HCWC has a Quick Ratio of 1.10. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
HCWC's Quick ratio of 0.58 is in line compared to the rest of the industry. HCWC outperforms 51.28% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.58
HCWC Yearly Current Assets VS Current LiabilitesHCWC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.68% over the past year.
HCWC shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.57%.
Measured over the past years, HCWC shows a very strong growth in Revenue. The Revenue has been growing by 83.46% on average per year.
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.11%
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%29.53%

3.2 Future

The Earnings Per Share is expected to grow by 24.21% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.78% on average over the next years. This is quite good.
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HCWC Yearly Revenue VS EstimatesHCWC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
HCWC Yearly EPS VS EstimatesHCWC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HCWC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HCWC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWC Price Earnings VS Forward Price EarningsHCWC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HCWC is valued a bit more expensive than 74.36% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HCWC indicates a rather cheap valuation: HCWC is cheaper than 92.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.27
EV/EBITDA 38.75
HCWC Per share dataHCWC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as HCWC's earnings are expected to grow with 24.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.21%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCWC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHY CHOICE WELLNESS CORP

NYSEARCA:HCWC (10/10/2025, 9:32:51 PM)

After market: 0.677 +0.01 (+1.04%)

0.67

+0.04 (+5.93%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)N/A N/A
Inst Owners1.19%
Inst Owner Change0%
Ins Owners14.76%
Ins Owner Change0%
Market Cap9.25M
Analysts82.86
Price Target2.04 (204.48%)
Short Float %0.77%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.98%
Min EPS beat(2)31.37%
Max EPS beat(2)70.59%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.19%
Min Revenue beat(2)4.54%
Max Revenue beat(2)5.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF 5.27
P/OCF 4.41
P/B 1.6
P/tB N/A
EV/EBITDA 38.75
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.13
FCFY18.99%
OCF(TTM)0.15
OCFY22.67%
SpS5.68
BVpS0.42
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.71%
ROE -73.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.65%
FCFM 2.24%
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
F-Score6
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 5.54
Debt/EBITDA 23.56
Cap/Depr 19.85%
Cap/Sales 0.43%
Interest Coverage N/A
Cash Conversion 569.03%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.58
Altman-Z 2.18
F-Score6
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)22.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.11%
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%29.53%
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.36%
OCF growth 3YN/A
OCF growth 5YN/A